drugset / Trial / NCT02606448
Exparel Infiltration in Anterior Cruciate Ligament Reconstruction
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a randomized, single blinded, standard of care controlled clinical trial. All adult patients over sixteen desiring anterior cruciate ligament reconstruction will be eligible. The study compares pain control and opioid consumption in patients undergoing ACL reconstruction between patients receiving liposomal bupivacaine and those who underwent a preoperative femoral nerve block.
Timeline
- Start
- 2014-08
- Primary completion
- 2015-09
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 133 mg | Other |
| Comparator | Ropivacaine | Other / unclassified | — | — |
Indications
No indication recorded.